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Acute-on-chronic liver failure: MELD score 30-day
mortality predictability and etiology in a Pakistani
population.
 
 
 
 
Original Article
Background: Cirrhosis is a pathological condition that ultimately leads to liver failure.
Acute on chronic liver failure (ACLF) has a high short term mortality rate. Viral hepatitis is
the most common cause of liver failure in our local population. We carried out this study to
identity the 30-day mortality and etiology of patients presenting with ACLF using Model for
End-Stage Liver Disease (MELD) score predictability.
Methodology: This was a descriptive case series, conducted at Sheikh Zayed Hospital,
Lahore, Pakistan from January 31, 2018 to July 30, 2018. One hundred and eighty five
patients who met the inclusion criteria were enrolled using 95% confidence level and 4%
margin of error. Data was entered and analyzed with SPSS version 23.0. Numerical
variables including age was presented by Mean ± S.D. Categorical variables i.e. gender,
etiology of acute-on-chronic liver failure and 30-day mortality were presented by frequency
and percentage. Data was stratified for age, gender, duration of chronic liver disease and
MELD grade to address the effect modifiers. Post-stratification chi-square test was
calculated using 95% significance (p≤0.05).
Results: Majority of the enrolled patients were male (74.6%) while only 25.4% of the
patients were female. One hundred and thirty patients (70.3%) had underlying viral
hepatitis while twelve patients (6.5%) and forty three patients (23.2%) presented with
alcoholic liver disease and drug-induced ACLF, respectively. Eighty patients (43.2%) died
within 30 days of admission.The 30-day mortality with respect to MELD grade was
statistically significant (p<0.001) with the highest mortality noted in grade-IV and thirty five
patients (43.8%) dying within 30 days of admission (p<0.001). Grade-II and III MELD
scores also contributed to the 30-day mortality with twenty three patients (28.8%) and
nineteen patients (23.8%) dying within 30 days of admission (p<0.001).
Conclusion: MELD scores are able to accurately predict the short-term mortality in
patients with ACLF and viral hepatitis was the most common etiology in our population.
Early detection and use of appropriate prognostic models may alleviate mortality and
morbidity in paitents with ACLF.
Keywords: Acute-on-chronic liver failure, model for end-stage liver disease, cirrhosis,
etiology, short-term mortality.
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ABSTRACT
INTRODUCTION
Cirrhosis is a pathological condition defined by diffuse
fibrosis, disruption of the intrahepatic arterial and
venous flow, portal hypertension and leading to liver
failure. Two phases of cirrhosis have been identified,
compensated and decompensated. While
compensated cirrhosis is asymptomatic,
decompensated cirrhosis manifests with ascites,
variceal haemorrhage and/or hepatic encephalopathy
with a mean survival of approximately 3-5 years.
Unless contraindications are present, patients may need
to be evaluated for liver transplant. Depending on the
underlying etiology, the decompensated cirrhosis may be
reversed, such as due to alcohol abuse, obesity or
chronic viral hepatitis. Acute on chronic liver failure
(ACLF) is defined as acute decomposition of cirrhosis
associated with organ failure and high short-term 28-day
mortality. This is a separate entity when compared to
decompensated hepatic cirrhosis due to occurrence of 
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One hundred and eighty five patients presenting to the
emergency department of Gastroenterology at Sheikh
Zayed Hospital, Lahore who met the inclusion criteria
were enrolled into our study. Detailed history and written
informed consent to participate in the study was taken
from each patient. The patients’ age and gender were
noted and they were evaluated for ACLF as per
operational definitions. The patients were managed as
per standard departmental protocols. The 30-day
mortality was recorded as well as demographic details
and etiology in the attached proforma. Laboratory testing
was acquired at Sheikh Zayed hospital and the patients
were managed by a single medical team to minimize
bias. Confounding variables were controlled by exclusion.
organ failure, systemic inflammation, specific
precipitating factors and high risk mortality. In the
Indian population, frequently-identified etiologies in
patients presenting with ACLF include alcoholism
followed by viral hepatitis and drugs. The 30-day
mortality in patients with ACLF ranged from 42.6% till
55% in the Indian Population. However, the 30-day
mortality in the Bangladeshi population was much
lower at 16.67%. In the Pakistani population, the most
frequent etiology of ACLF was viral hepatitis (33.3%)
followed by drugs (23.6%) while alcoholic liver disease
was identified in only 8.3% of the patients. In the same
cohort, the 30-day mortality was 39.3% in patients
presenting to the Sindh Institute of Urology and
Transplantation (SIUT), Karachi. Patients with higher
Model for End-Stage Liver Disease (MELD) scores had
a higher frequency of mortality (66.7% vs. 33.3%;
p=0.001) using MELD<30 vs. MELD ≥30. There are
wide variations globally regarding the frequency of
mortality with limited data in the Pakistani population. In
Pakistan, viral hepatitis has been identified as the most
common underlying etiology for ACLF. However, there
are considerable geographic differences regarding the
prevalence of viral hepatitis across Pakistan. The
following study aims to identity the 30-day mortality and
etiology of patients presenting with ACLF to a tertiary
care hospital using Model for End-Stage Liver Disease
(MELD) score predictability.
Viral Hepatitis: Patient diagnosed with Hepatitis A,
B, C and E by ELISA.
Alcoholism: Patients presenting with history of
alcoholism in ≤6 months with gamma glutamyl
transferase (γGGT) ≥50 IU/lit in serum.
Drug Induced: Patients presenting with history of
one or more of the following medication in the
preceding 2 weeks:
General anesthesia
Halothane
Chloroform
Isoflurane, Enflurane, Desflurane
Nitrous oxide
Interferon therapy
Anti-Tuberculous Therapy
Homeopathic medication
Herbal medication
c. Grade-III: 19-24
d. Grade-IV: 25-40
c) Etiological spectrum:
a.
b.
c.
i.
1.
2.
3.
4.
ii.
iii.
iv.
v.
d) 30-day Mortality: Death of enrolled patients within 30
days of presentation to the hospital.
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SUBJECTS AND METHODS
Grade-I: 6-10
Grade-II: 11-18
a) Acute-on Chronic Liver Failure (ACLF): Liver
cirrhosis was diagnosed with the following 2 criteria on
ultrasonography:
1) coarse shrunken liver and 2) dilated portal vein (>50
x normal).
Diagnosed cases of liver cirrhosis for duration of
disease of ≥1 year who presented with jaundice (total
bilirubin >5 mg/dl) and coagulopathy (international
normalised ratio ≥1.5) were then selected with a
diagnosis of acute-on chronic liver failure.
b) Model for End-Stage Liver Disease (MELD)
Grading: Patients diagnosed with ALCF within the last
24 hours who were included in the study and were
graded per Model for End-Stage Liver Disease
(MELD):
a.
b.
Sample size of 185 was calculated with 95% confidence
level and 4% margin of error while estimating expected
percentage of drug induced hepatitis as 8.3% in patients
with ACLF. The subjects were selected by non-probability
consecutive sampling.
Sample Size
Inclusion Criteria
Patients with chronic renal disease (serum creatinine
levels ≥1.5 mg/dl), heart failure (ejection fraction ≤60%),
respiratory failure (SpO2/FiO2<214) and/or cancer
(diagnosed cases as preclinical record).
Operational Definitons
Adult patients of either gender, aged 20-60 years and
diagnosed with acute-on-chronic liver failure (as per
operational definition) in the last 24 hours.
Data Collection
[4-7]
[4,5]
[8]
[9]
[9]
[9]
[10-12]
This was a descriptive case series, conducted at
department of gastroenterology, Sheikh Zayed
Hospital, Lahore, Pakistan from January 31st 2018 to
July 30th 2018.
[9]
Exclusion Criteria
15
score in ACLF as a prognostic marker in our local
Pakistani population. Acute-on-chronic liver failure
(ACLF) is prevalent in the South-Asian population due to
high burden of viral hepatitis. However, no prognostic
models have been developed with specific data in this
target population. ACLF presents with multiple
complications and has a short-term mortality rate of 50-
90%. While the most effective treatment modality is liver
transplantation, there is a dearth of liver donors and the
cost of procedures are high. It is crucial to diagnose and
determine the prognosis of patients with ACLF in order to
categorize patients in need of liver transplantation or only
intensive medical care. The most commonly used model
for its prognostic potential in ACLF is the model for end-
stage liver disease (MELD) scoring system and it was
established to determine the short-term prognosis in
patients with liver cirrhosis who were undergoing
transjugular intrahepatic portosystemtic shunts as well as
to categorize the urgency of patients requiring liver
transplantation by the United Network for Organ Sharing
(UNOS). MELD is based on three easily attainable
biochemical variables including serum bilirubin, serum
creatinine, and international normalized ratio (INR) of
prothrombin time. The modified MELD scoring system
incorporates the measurement of serum sodium levels. In
January 2016, the Organ Procuerment and
Transplantation Network Policy 9.1 was updated to
include serum sodium in the MELD score grading
system. The model has been shown to accurately predict
the short-term mortality of patients independent of
etiology and complications such as portosystemic
encephalopathy and spontaneous baceterial peritonitis.
Previous data indicates the validation of MELD score in
predicting the 3-month mortality in cirrhotic patients.
However, these models may not be ideal for use in the
Pakistani population and their potential to predict
outcomes of patients in non-transplantation setting is not
entirely clear. The prognosis of ACLF is dependent on
multiple factors including multi-organ failure and brain
oadema. Since MELD scores rely on serum markers
including creatininem, INR and bilirubin, it is likely that
correction of these measures via methods including
plasma exchange or replacement therapy may negatively
skew the MELD scores. It is important to interpret MELD
scores with precaution since better scores may not be
representative of the severity of disease in the patients.
Our study reports a high short-term 30-day mortality rate,
43.2%, in patients admitted due to ACLF. The MELD
scoring system was used to categorize the severity of
ACLF and the results are statistically significance for
predicting the 30-day mortality with respect to MELD 
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Data was entered and analyzed using SPSS version
23.0. Numerical variables including age was presented
by Mean ± S.D. Categorical variables i.e. gender,
etiology of acute-on-chronic liver failure and 30-day
mortality were presented by frequency and percentage.
Data was stratified for age, gender, duration of chronic
liver disease and MELD grade to address the effect
modifiers. Post-stratification chi-square test was
calculated using 95% significance (p≤0.05).
Majority of the enrolled patients were male (74.6%)
while only 25.4% of the patients were female [Table 1].
Seventy six patients were >50 years (41.1%) while
sixty patients (32.4%) and forty nine patients (26.5%)
were between 36-50 and 20-35 years, respectively
[Table 2].
The duration of cirrhosis was 1-3 years in sixty seven
patients (36.2%), 3-5 years in sixty one patients (33%)
and >5 years in fifty seven patients (30.8%) [Table 3].
Thirty seven patients (20.0%) had MELD grade-I, while
forty six patients (24.9%), fifty three patients (28.6%)
and forty nine (26.5%) patients presented with MELD
grades-II, III and IV respectively [Table 4].
One hundred and thirty patients (70.3%) had
underlying viral hepatitis while twelve patients (6.5%)
and forty three patients (23.2%) presented with
alcoholic liver disease and drug-induced ACLF,
respectively [Table 5].
Eighty patients (43.2%) died within 30 days of
admission [Table 6].
The 30-day mortality with respect to MELD grade was
statistically significant (p<0.001) with the highest
mortality noted in grade-IV with thirty five patients
(43.8%) dying within 30 days of admission (p<0.001)
(Table 7). Grade-II and III MELD scores also
contributed to the 30-day mortality with twenty three
patients (28.8%) and nineteen patients (23.8%) dying
within 30 days of admission (p<0.001) [Table 7].
There was no statistical significance of gender-based
etiology (p<0.770) and gender-based 30-day mortality
(p<0.210). Additionally, no statistical significance was
observed for gender-based etiology (p<0.770), gender-
based 30-day mortality (p<0.210), age-based etiology
(p<0.170) and age-based 30-day mortality (p<0.801).
The etiology of ACLF (p<0.437) and 30-day mortality
(p<0.605) with respect to duration of disease was not
statistically significant (p<0.437). The etiology of ACLF
with respect to MELD score was also insignificant
(p<0.389).
RESULTS
This is a novel study as it assesses the role of MELD 
DISCUSSION
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Data Analysis
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Table 1: Frequency distribution of gender.
Table 2: Frequency distribution of age groups.
Table 3: Frequency distribution of duration of disease
Table 4: Frequency distribution of MELD grade.
Table 5: Frequency distribution of etiology of ACLF.
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Table 6: Frequency distribution of 30-days mortality.
Table 7: Stratification of 30-days mortality with respect to MELD grade.
scores. This study has shown strong validity of MELD
scores for prediction of short-term mortality with
regards to its sensitivity and specificity. However, there
are concerns regarding the use of the MELD grading
system. Of primary concern is whether the MELD
prognostic model takes into account complications
including esophageal varices, spontaneous bacterial
peritonitis and other related complications.
CONCLUSION
The prospective study presents data for 30-day
mortality and etiology of patients admitted with acute-
on-chronic liver failure in a tertiary care hospital. The
MELD score grading system is able to accurately
predict the short-term mortality in patients with ACLF.
Viral hepatitis was the most common etiology of
cirrhosis in our population. These findings are
consistent with previous studies that were conducted to
validate the MELD score grading system as a liver
disease severity index. While our study did not
compare other prognostic models, application of the
MELD score grading system needs to be scrutinized for
use in the South-Asian population before being used
for its predictive potential in short-term mortality of
patients with ACLF.
LIMITATIONS
Our study has a few limitatations. First, we collected data
from a single center that may introduce bias. Second, our
sample size was small and we used a single MELD score
instead of serial delta scores. Third, we did not compare
MELD scores with other prognostic models. Last, the cut-
offs used for the MELD scores in our study have not been
validated by other studies in the South-Asian population.
It may be of use to identify and validate accurate scoring
systems for the South-Asian population which may lead
to better survival in the population. Appropriate cut-points
help isolate patients at risk of high mortality further
prompting aggressive and correct management.[21]
REFERENCES
Hernaez R, Solà E, Moreau R, Ginès P. Acute-on-
chronic liver failure: an update. Gut. 2017;66(3):541-
553. Available from: doi: 10.1136/gutjnl-2016-312670.
Jalan R, Pavesi M, Saliba F, Amorós A, Fernandez J,
Holland-Fischer P, Sawhney R, Mookerjee R,
Caraceni P, Moreau R, Ginès P, Durand F, Angeli P,
Alessandria C, Laleman W, Trebicka J, Samuel D,
Zeuzem S, Gustot T, Gerbes AL, Wendon J, Bernardi
M, Arroyo V; CANONIC Study Investigators; EASL-
CLIF Consortium. The CLIF Consortium Acute
Decompensation score (CLIF-C ADs) for prognosis of
hospitalised cirrhotic patients without acute-on-chronic
liver failure. J Hepatol. 2015;62(4):831-40. Available
from: doi: 10.1016/j.jhep.2014.11.012.
Alam A, Chun Suen K, Ma D. Acute-on-chronic liver
failure: recent update. J Biomed Res. 2017;31(4):283-
300. doi: 10.7555/JBR.30.20160060.
Jain R, Thakur MB. Acute on Chronic Liver Failure: 
1.
2.
3.
4.
Edwards EB, Malinchoc M, Kremers WK, Krom RA,
Kim WR. MELD and PELD: application of survival
models to liver allocation. Liver Transpl.
2001;7(7):567-80. Available from: doi:
10.1053/jlts.2001.25879.
19. Kamath PS, Wiesner RH, Malinchoc M, Kremers
W, Therneau TM, Kosberg CL, D'Amico G, Dickson
ER, Kim WR. A model to predict survival in patients
with end-stage liver disease. Hepatology.
2001;33(2):464-70. Available from: doi:
10.1053/jhep.2001.22172.
20. Schmidt LE, Larsen FS. MELD score as a
predictor of liver failure and death in patients with
acetaminophen-induced liver injury. Hepatology.
2007;45(3):789-96.Available from: doi:
10.1002/hep.21503.
21. Choudhary NS, Saraf N, Saigal S, Soin AS. Liver
Transplantation for Acute on Chronic Liver Failure. J
Clin Exp Hepatol. 2017;7(3):247-252. doi:
10.1016/j.jceh.2017.08.001.
Feb - April 2020 | Vol 1 issue 1 34
Pakistan Journal of Surgery & Medicine
Causative Factors and Comparison of Prognostic
Scores. J Liver Res Disord Ther. 2016;1(3):00015.
5. Shalimar, Saraswat V, Singh SP, Duseja A,
Shukla A, Eapen CE, Kumar D, Pandey G,
Venkataraman J, Puri P, Narayanswami K, Dhiman
RK, Thareja S, Nijhawan S, Bhatia S, Zachariah U,
Sonika U, Varghese T, Acharya SK. Acute-on-
chronic liver failure in India: The Indian National
Association for Study of the Liver consortium
experience. J Gastroenterol Hepatol. 2016
;31(10):1742-1749. Available from: doi:
10.1111/jgh.13340.
6. Alempijevic T, Zec S, Nikolic V, Veljkovic A,
Milivojevic V, Dopsaj V, Stankovic S, Milosavljevic T.
Erythropoietin in Predicting Prognosis in Patients
with Acute-on-Chronic Liver Failure. J Gastrointestin
Liver Dis. 2016 Dec;25(4):473-479. doi:
10.15403/jgld.2014.1121.254.jev.
7. Peng Y, Qi X, Tang S, Deng H, Li J, Ning Z, Dai
J, Hou F, Zhao J, Wang R, Guo X. Child-Pugh,
MELD, and ALBI scores for predicting the in-hospital
mortality in cirrhotic patients with acute-on-chronic
liver failure. Expert Rev Gastroenterol Hepatol. 2016
Aug;10(8):971-80. doi:
10.1080/17474124.2016.1177788.
8. Khatun UF, Sayeed A, Hussain SM, Paul S,
Kawsar NM, Al-Azad MA. Etiological study of acute
on chronic liver failure among patients admitted in
medicine ward in Chittagong Medical College
Hospital. Journal of Armed Forces Medical College,
Bangladesh. 2013;9(2):77-82.
9. Tasneem AA, Luck NH. Acute-On-Chronic Liver
Failure: Causes, Clinical Characteristics and
Predictors of Mortality. J Coll Physicians Surg Pak.
2017 Jan;27(1):8-12.
10. Sana RI, Iqbal A. A review of hepatitis C in the
general population in Pakistan. Viral Hepatit
Dergisis. 2016;22(3):74.
11. Bosan A, Qureshi H, Bile KM, Ahmad I, Hafiz R.
A review of hepatitis viral infections in Pakistan. J
Pak Med Assoc. 2010 ;60(12):1045-58.
12. Umer M, Iqbal M. Hepatitis C virus prevalence
and genotype distribution in Pakistan:
Comprehensive review of recent data. World J
Gastroenterol. 2016;22(4):1684-700. Available from:
doi: 10.3748/wjg.v22.i4.1684.
13. Xia Q, Dai X, Zhang Y, Guo Y, Xu X, Yang Q,
Du W, Liu X, Chen Y, Huang J, Li L. A modified
MELD model for Chinese pre-ACLF and ACLF
patients and it reveals poor prognosis in pre-ACLF
patients. PLoS One. 2013;8(6):e64379. Available
from: doi: 10.1371/journal.pone.0064379.
14. Katoonizadeh A, Laleman W, Verslype C,
Wilmer A, Maleux G, Roskams T, Nevens F. Early
features of acute-on-chronic alcoholic liver failure: a
prospective cohort study. Gut. 2010;59(11):1561-9.
doi: 10.1136/gut.2009.189639.
15. Wlodzimirow KA, Eslami S, Abu-Hanna A,
Nieuwoudt M, Chamuleau RA. A systematic review
on prognostic indicators of acute on chronic liver
failure and their predictive value for mortality. Liver
Int. 2013;33(1):40-52. doi: 10.1111/j.1478-
3231.2012.02790.x.
16. Malinchoc M, Kamath PS, Gordon FD, Peine CJ,
Rank J, ter Borg PC. A model to predict poor
survival in patients undergoing transjugular
intrahepatic portosystemic shunts. Hepatology.
2000;31(4):864-71. doi: 10.1053/he.2000.5852.
17. Biggins SW, Kim WR, Terrault NA, Saab S,
Balan V, Schiano T, Benson J, Therneau T,
Kremers W, Wiesner R, Kamath P, Klintmalm G.
Evidence-based incorporation of serum sodium
concentration into MELD. Gastroenterology. 2006
;130(6):1652-60. Available from: doi:
10.1053/j.gastro.2006.02.010.
18. Wiesner RH, McDiarmid SV, Kamath PS, 
CONFLICT OF INTEREST
The Authors declared no conflicts of interest.
Copyright © 2020 Pakistan Journal of Surgery &
Medicine. This is an open-access article distributed
under the terms of the Creative Commons Attribution
4.0 License, which permits unrestricted use, distribution
& reproduction in any medium provided that original
work is cited properly.
COPYRIGHT STATEMENT
E-OP
We Value your Opinions. Register your Opinion to this
Original Article by Sarfraz A et  al. by clicking here.
HOW TO CITE
Sarfraz A, Sarfraz M, Gilani NA, Siddiq J, Sattar S,
Khalid T. Acute-on-chronic liver failure: MELD score
30-day mortality predictability and etiology in a
Pakistani population. Pak J Surg Med. 2020;1(1):29-34.
doi:  10.5281/zenodo.3595095.
